Related Experiment Videos
[Malignant lymphomas of the thyroid gland]
Wiener Klinische Wochenschrift
|April 27, 1990
Summary
Improved treatments for malignant thyroid lymphoma significantly increased patient survival rates between 1979 and 1989 compared to earlier methods. Modern high-voltage irradiation and chemotherapy offer better outcomes for thyroid cancer patients.
Area of Science:
- Oncology
- Surgical Pathology
Context:
- Malignant lymphomas of the thyroid gland are rare but aggressive neoplasms.
- Treatment strategies have evolved significantly over time.
Purpose:
- To evaluate the impact of changing postoperative management on survival outcomes for thyroid malignant lymphoma patients.
- To compare the efficacy of conventional irradiation versus modern high-voltage irradiation and chemotherapy.
Summary:
- A retrospective analysis of 43 thyroid malignant lymphoma cases (1957-1989) treated at Kaiser Elisabeth hospital.
- Patients receiving conventional irradiation (1957-1978) had a mean survival of 5 months, with all patients eventually dying.
- Patients treated with high-voltage irradiation and/or chemotherapy (1979-1989) showed a significantly improved mean survival of 39 months, with 90% remission rates in survivors.
Impact:
- Modern treatment protocols including high-voltage irradiation and chemotherapy have dramatically improved survival for malignant thyroid lymphoma.
- Advancements in surgical techniques, hematological staging, and combined-modality treatment contribute to better patient prognoses.